Details

NameSymbolSector
ERIS LIFESCIENCES LIMITEDERISPharmaceuticals
Open
1408.7
High
1409.8
Low
1380.3
Close
1384.4
Volume
54697
Exchange
nse
Time
15-Jun-2026

Outlook

Score:  

2.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Eris Lifesciences is  
Opening Marubozu
Estimated Stoploss of Eris Lifesciences is ₹  
1409.8
Eris Lifesciences has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Eris Lifesciences has chances of  
Continuationℹ
 of the current trend. 

Trend

Eris Lifesciences is in  
Sideways trendℹ
. 
Price of Eris Lifesciences is  
Upℹ
 by  

1.15

%. 
Target
Buy @ 

1272.26

Sell @ 

1442.64

Current @ 

1384.4

Volume

The trade volumes of Eris Lifesciences have become  
Deficientℹ
Though the volume trend for Eris Lifesciences appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Eris Lifesciences is  

Down

 by  

59.22

% 

Valuation

The current market price of Eris Lifesciences is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 7033cr and total assets worth ₹ 7033cr, the balance sheet of Eris Lifesciences is:  
Balancedℹ
. 
Cashflow
Eris Lifesciences has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 105cr

. It is  
Upℹ
 by  

854.55

%. 

(*Mar 2025)

52.57% i.e. ₹ 1065cr earned in operatingℹ
3.9% i.e. ₹ 79cr spent in investingℹ
43.48% i.e. ₹ 881cr spent in financingℹ
0.05% i.e. ₹ 1cr earned in otherℹ
Eris Lifesciences has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 11cr

. It is  
Upℹ
 by  

120

%. 

(*Mar 2024)

13.07% i.e. ₹ 486cr earned in operatingℹ
49.85% i.e. ₹ 1854cr spent in investingℹ
37.08% i.e. ₹ 1379cr earned in financingℹ
0% in otherℹ
Income
The income of Eris Lifesciences is  

₹ 795cr

 and  

Profit

 is :  

₹ 134cr

(*Sep 2025)

Eris Lifesciences Profit is up by:  

8.06

% and Income is Up by:  

2.58

% 

(*Sep 2025)

The income of Eris Lifesciences is  

₹ 775cr

 and  

Profit

 is :  

₹ 124cr

(*Jun 2025)

Eris Lifesciences Profit is up by:  

21.57

% and Income is Up by:  

8.7

% 

(*Jun 2025)

The income of Eris Lifesciences is  

₹ 713cr

 and  

Profit

 is :  

₹ 102cr

(*Mar 2025)

Eris Lifesciences Profit is up by:  

18.6

% and Income is Down by:  

2.46

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.